The Pharmaceutical Market: Saudi Arabia

Summary

This In-Depth Pharmaceutical Market Reports Are Ideal For Executives Wanting To Understand The Key Drivers In Pharmaceutical Markets And Have Access To A Wealth Of Statistical Data. Each Report Opens With An Outlook Section That Provides Analysis Of The Market, 5-Year Market Forecasts, National Data Projections, Market Outlook And Key Developments Such As Regulation, Pricing/Reimbursement, Intellectual Property, Health Facilities And Government Policy. The Report Also Provides Extensive Background Information, Population Trends, Health Status, Health Expenditure, Organisation & Administration, Hospital Services, Medical Personnel, Healthcare Development, Market Access Information, Trade Data For Raw Materials And Finished Products And Essential Industry Contacts. Included With The Report Are 3 Free Quarterly Updated Outlook Reports, Enabling You To Keep Up To Date With Market Developments For A Year.

Saudi Arabia Is The Largest And Richest Of The Gulf States. The Country's Wealth Derives Principally From Its Vast Reserves Of Oil And Natural Gas, And Has Enabled The Development Of A Sophisticated Healthcare System Over The Last 30 Years. Saudi Hospitals Are Among The Best In The Middle East, While Specialised Tertiary Facilities Bear Comparison With Facilities In Western Europe.

In Recent Years, The Government Has Had To Overcome A Number Of Problems In Improving The Healthcare System, Including Volatile Oil Prices, The Asian Economic Crisis And Political Instability In The Middle East. Despite These Setbacks, Government Health Spending Has Continued To Increase, Illustrating The Commitment Of The Saudi Government To Providing Comprehensive Healthcare For The Whole Population. A Further Problem Is The Rapid Growth Of The Saudi Population. Currently Standing At Just Under 3% Per Annum, It Represents One Of The Highest Rates In The World. As A Result, If Current Healthcare Services And Coverage Are To Be Maintained, Even Higher Levels Of Healthcare Investment Will Be Needed In The Future.

It Appears To Be Recognised By The Government That A Free Universal Public Health System Is Becoming Increasingly Untenable. A Compulsory Health Insurance Scheme For Expatriate Workers Has Been Introduced And Is Widely Seen As A Blueprint For A System Covering Saudi Nationals. In The Meantime, The Current System Is Likely To Be Maintained By Government Spending Boosts Where Possible, And By The Private Sector, Which Offers Advanced But Expensive Facilities.

The Saudi Pharmaceutical Market Is One Of The Richest In The Middle East, Although It Is Marked By Tight Price Controls And Late Payment For Tenders, Especially In The Public Sector, Where Funding Is Dependent On Oil Revenues. Imported Products Account For Around 90% Of The Market, With Very Little Manufacturing Being Undertaken Locally.

Content